Name | ID | Count | Percent (Study Genes) | Percent (Population Genes) | E value |
cellular lipid metabolism | GO:0044255 | 4 | 50% | 3.16% | 6.13E-5(0.1) |
lipid metabolism | GO:0006629 | 4 | 50% | 3.38% | 7.96E-5(0.13) |
phospholipid metabolism | GO:0006644 | 3 | 37.5% | 1.19% | 8.75E-5(0.14) |
MAPKKK cascade | GO:0000165 | 2 | 25% | 0.26% | 1.81E-4(0.29) |
membrane lipid metabolism | GO:0006643 | 3 | 37.5% | 1.61% | 2.14E-4(0.35) |
protein kinase cascade | GO:0007243 | 2 | 25% | 0.31% | 2.52E-4(0.41) |
lipid biosynthesis | GO:0008610 | 3 | 37.5% | 1.92% | 3.61E-4(0.58) |
phospholipid biosynthesis | GO:0008654 | 2 | 25% | 0.81% | 1.73E-3(n.s) |
membrane lipid biosynthesis | GO:0046467 | 2 | 25% | 1.1% | 3.2E-3(n.s) |
phosphoinositide phosphorylation | GO:0046854 | 1 | 12.5% | 0.06% | 4.95E-3(n.s) |
lipid phosphorylation | GO:0046834 | 1 | 12.5% | 0.06% | 4.95E-3(n.s) |
ethanolamine and derivative metabolism | GO:0042439 | 1 | 12.5% | 0.08% | 6.18E-3(n.s) |
phosphatidylethanolamine metabolism | GO:0046337 | 1 | 12.5% | 0.08% | 6.18E-3(n.s) |
ethanolamine metabolism | GO:0006580 | 1 | 12.5% | 0.08% | 6.18E-3(n.s) |
ethanolamine biosynthesis | GO:0046335 | 1 | 12.5% | 0.08% | 6.18E-3(n.s) |
phosphatidylethanolamine biosynthesis | GO:0006646 | 1 | 12.5% | 0.08% | 6.18E-3(n.s) |
intracellular signaling cascade | GO:0007242 | 2 | 25% | 1.66% | 7.14E-3(n.s) |
myo-inositol metabolism | GO:0006020 | 1 | 12.5% | 0.09% | 7.41E-3(n.s) |
negative regulation of transcription, DNA-dependent | GO:0045892 | 2 | 25% | 1.89% | 9.21E-3(n.s) |
negative regulation of transcription | GO:0016481 | 2 | 25% | 1.95% | 9.8E-3(n.s) |
protein secretion | GO:0009306 | 1 | 12.5% | 0.14% | 0.01(n.s) |
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolism | GO:0045934 | 2 | 25% | 2.11% | 0.01(n.s) |
negative regulation of cellular metabolism | GO:0031324 | 2 | 25% | 2.29% | 0.01(n.s) |
negative regulation of metabolism | GO:0009892 | 2 | 25% | 2.4% | 0.01(n.s) |
lipid modification | GO:0030258 | 1 | 12.5% | 0.19% | 0.01(n.s) |
alcohol metabolism | GO:0006066 | 2 | 25% | 2.43% | 0.01(n.s) |
phosphoinositide-mediated signaling | GO:0048015 | 1 | 12.5% | 0.2% | 0.02(n.s) |
inositol lipid-mediated signaling | GO:0048017 | 1 | 12.5% | 0.2% | 0.02(n.s) |
signal transduction | GO:0007165 | 2 | 25% | 2.59% | 0.02(n.s) |
negative regulation of cellular physiological process | GO:0051243 | 2 | 25% | 2.59% | 0.02(n.s) |
negative regulation of cellular process | GO:0048523 | 2 | 25% | 2.59% | 0.02(n.s) |
negative regulation of physiological process | GO:0043118 | 2 | 25% | 2.62% | 0.02(n.s) |
negative regulation of biological process | GO:0048519 | 2 | 25% | 2.71% | 0.02(n.s) |
nuclear migration, microtubule-mediated | GO:0030473 | 1 | 12.5% | 0.23% | 0.02(n.s) |
microtubule-based movement | GO:0007018 | 1 | 12.5% | 0.23% | 0.02(n.s) |
cytoskeleton-dependent intracellular transport | GO:0030705 | 1 | 12.5% | 0.25% | 0.02(n.s) |
response to heat | GO:0009408 | 1 | 12.5% | 0.26% | 0.02(n.s) |
biogenic amine biosynthesis | GO:0042401 | 1 | 12.5% | 0.29% | 0.02(n.s) |
cell communication | GO:0007154 | 2 | 25% | 3.08% | 0.02(n.s) |
amino acid derivative biosynthesis | GO:0042398 | 1 | 12.5% | 0.31% | 0.02(n.s) |
nuclear positioning | GO:0040023 | 1 | 12.5% | 0.31% | 0.02(n.s) |
response to temperature | GO:0009266 | 1 | 12.5% | 0.31% | 0.02(n.s) |
nuclear migration | GO:0007097 | 1 | 12.5% | 0.31% | 0.02(n.s) |
organelle organization and biogenesis | GO:0006996 | 4 | 50% | 15.69% | 0.02(n.s) |
secretion | GO:0046903 | 2 | 25% | 3.24% | 0.03(n.s) |
biogenic amine metabolism | GO:0006576 | 1 | 12.5% | 0.39% | 0.03(n.s) |
amino acid derivative metabolism | GO:0006575 | 1 | 12.5% | 0.42% | 0.03(n.s) |
protein-ER targeting | GO:0045047 | 1 | 12.5% | 0.43% | 0.03(n.s) |
second-messenger-mediated signaling | GO:0019932 | 1 | 12.5% | 0.43% | 0.03(n.s) |
establishment of protein localization | GO:0045184 | 2 | 25% | 3.95% | 0.04(n.s) |
phosphoinositide metabolism | GO:0030384 | 1 | 12.5% | 0.48% | 0.04(n.s) |
cell organization and biogenesis | GO:0016043 | 4 | 50% | 17.98% | 0.04(n.s) |
steroid biosynthesis | GO:0006694 | 1 | 12.5% | 0.56% | 0.04(n.s) |
protein localization | GO:0008104 | 2 | 25% | 4.37% | 0.04(n.s) |
vacuole organization and biogenesis | GO:0007033 | 1 | 12.5% | 0.59% | 0.05(n.s) |
cytoskeleton organization and biogenesis | GO:0007010 | 2 | 25% | 4.48% | 0.05(n.s) |
negative regulation of transcription from RNA polymerase II promoter | GO:0000122 | 1 | 12.5% | 0.64% | 0.05(n.s) |
regulation of transcription, DNA-dependent | GO:0006355 | 2 | 25% | 4.68% | 0.05(n.s) |
telomeric heterochromatin formation | GO:0031509 | 1 | 12.5% | 0.67% | 0.05(n.s) |
chromatin silencing at telomere | GO:0006348 | 1 | 12.5% | 0.67% | 0.05(n.s) |
glycerophospholipid metabolism | GO:0006650 | 1 | 12.5% | 0.68% | 0.05(n.s) |
steroid metabolism | GO:0008202 | 1 | 12.5% | 0.7% | 0.05(n.s) |
regulation of transcription | GO:0045449 | 2 | 25% | 4.96% | 0.06(n.s) |
positive regulation of transcription from RNA polymerase II promoter | GO:0045944 | 1 | 12.5% | 0.74% | 0.06(n.s) |
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolism | GO:0019219 | 2 | 25% | 5.24% | 0.06(n.s) |
positive regulation of transcription, DNA-dependent | GO:0045893 | 1 | 12.5% | 0.91% | 0.07(n.s) |
positive regulation of transcription | GO:0045941 | 1 | 12.5% | 1.01% | 0.08(n.s) |
nuclear organization and biogenesis | GO:0006997 | 1 | 12.5% | 1.01% | 0.08(n.s) |
regulation of cellular metabolism | GO:0031323 | 2 | 25% | 5.98% | 0.08(n.s) |
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolism | GO:0045935 | 1 | 12.5% | 1.02% | 0.08(n.s) |
response to stress | GO:0006950 | 2 | 25% | 6.09% | 0.08(n.s) |
positive regulation of cellular metabolism | GO:0031325 | 1 | 12.5% | 1.05% | 0.08(n.s) |
positive regulation of metabolism | GO:0009893 | 1 | 12.5% | 1.05% | 0.08(n.s) |
positive regulation of physiological process | GO:0043119 | 1 | 12.5% | 1.1% | 0.08(n.s) |
positive regulation of cellular process | GO:0048522 | 1 | 12.5% | 1.1% | 0.08(n.s) |
positive regulation of cellular physiological process | GO:0051242 | 1 | 12.5% | 1.1% | 0.08(n.s) |
regulation of metabolism | GO:0019222 | 2 | 25% | 6.37% | 0.09(n.s) |
negative regulation of gene expression, epigenetic | GO:0045814 | 1 | 12.5% | 1.19% | 0.09(n.s) |
chromatin silencing | GO:0006342 | 1 | 12.5% | 1.19% | 0.09(n.s) |
gene silencing | GO:0016458 | 1 | 12.5% | 1.19% | 0.09(n.s) |
heterochromatin formation | GO:0031507 | 1 | 12.5% | 1.19% | 0.09(n.s) |
positive regulation of biological process | GO:0048518 | 1 | 12.5% | 1.21% | 0.09(n.s) |
establishment of localization | GO:0051234 | 3 | 37.5% | 14.39% | 0.1(n.s) |
regulation of gene expression, epigenetic | GO:0040029 | 1 | 12.5% | 1.27% | 0.1(n.s) |
chromatin assembly | GO:0031497 | 1 | 12.5% | 1.27% | 0.1(n.s) |
transcription, DNA-dependent | GO:0006351 | 2 | 25% | 6.78% | 0.1(n.s) |
microtubule cytoskeleton organization and biogenesis | GO:0000226 | 1 | 12.5% | 1.32% | 0.1(n.s) |
hexose metabolism | GO:0019318 | 1 | 12.5% | 1.32% | 0.1(n.s) |
localization | GO:0051179 | 3 | 37.5% | 14.82% | 0.1(n.s) |
monosaccharide metabolism | GO:0005996 | 1 | 12.5% | 1.43% | 0.11(n.s) |
transcription | GO:0006350 | 2 | 25% | 7.43% | 0.11(n.s) |
chromatin assembly or disassembly | GO:0006333 | 1 | 12.5% | 1.52% | 0.12(n.s) |
intracellular transport | GO:0046907 | 2 | 25% | 7.53% | 0.12(n.s) |
microtubule-based process | GO:0007017 | 1 | 12.5% | 1.55% | 0.12(n.s) |
actin cytoskeleton organization and biogenesis | GO:0030036 | 1 | 12.5% | 1.55% | 0.12(n.s) |
actin filament-based process | GO:0030029 | 1 | 12.5% | 1.61% | 0.12(n.s) |
amine biosynthesis | GO:0009309 | 1 | 12.5% | 1.67% | 0.13(n.s) |
nitrogen compound biosynthesis | GO:0044271 | 1 | 12.5% | 1.67% | 0.13(n.s) |
response to stimulus | GO:0050896 | 2 | 25% | 8.41% | 0.14(n.s) |
regulation of cellular physiological process | GO:0051244 | 2 | 25% | 8.49% | 0.14(n.s) |
regulation of cellular process | GO:0050794 | 2 | 25% | 8.52% | 0.14(n.s) |
chromatin remodeling | GO:0006338 | 1 | 12.5% | 2.01% | 0.15(n.s) |
regulation of physiological process | GO:0050791 | 2 | 25% | 8.77% | 0.15(n.s) |
regulation of biological process | GO:0050789 | 2 | 25% | 8.97% | 0.16(n.s) |
phosphorylation | GO:0016310 | 1 | 12.5% | 2.21% | 0.16(n.s) |
biosynthesis | GO:0009058 | 3 | 37.5% | 18.28% | 0.17(n.s) |
chromatin modification | GO:0016568 | 1 | 12.5% | 2.77% | 0.2(n.s) |
regulation of transcription from RNA polymerase II promoter | GO:0006357 | 1 | 12.5% | 2.8% | 0.2(n.s) |
phosphorus metabolism | GO:0006793 | 1 | 12.5% | 2.91% | 0.21(n.s) |
phosphate metabolism | GO:0006796 | 1 | 12.5% | 2.91% | 0.21(n.s) |
amino acid and derivative metabolism | GO:0006519 | 1 | 12.5% | 3.05% | 0.22(n.s) |
cellular carbohydrate metabolism | GO:0044262 | 1 | 12.5% | 3.08% | 0.22(n.s) |
secretory pathway | GO:0045045 | 1 | 12.5% | 3.13% | 0.22(n.s) |
DNA packaging | GO:0006323 | 1 | 12.5% | 3.14% | 0.23(n.s) |
establishment and/or maintenance of chromatin architecture | GO:0006325 | 1 | 12.5% | 3.14% | 0.23(n.s) |
amine metabolism | GO:0009308 | 1 | 12.5% | 3.38% | 0.24(n.s) |
carbohydrate metabolism | GO:0005975 | 1 | 12.5% | 3.38% | 0.24(n.s) |
protein targeting | GO:0006605 | 1 | 12.5% | 3.42% | 0.24(n.s) |
response to abiotic stimulus | GO:0009628 | 1 | 12.5% | 3.52% | 0.25(n.s) |
nitrogen compound metabolism | GO:0006807 | 1 | 12.5% | 3.66% | 0.26(n.s) |
intracellular protein transport | GO:0006886 | 1 | 12.5% | 3.7% | 0.26(n.s) |
chromosome organization and biogenesis (sensu Eukaryota) | GO:0007001 | 1 | 12.5% | 3.72% | 0.26(n.s) |
protein transport | GO:0015031 | 1 | 12.5% | 3.79% | 0.27(n.s) |
response to external stimulus | GO:0009605 | 1 | 12.5% | 3.87% | 0.27(n.s) |
chromosome organization and biogenesis | GO:0051276 | 1 | 12.5% | 3.9% | 0.27(n.s) |
transcription from RNA polymerase II promoter | GO:0006366 | 1 | 12.5% | 4.29% | 0.3(n.s) |
cellular process | GO:0009987 | 7 | 87.5% | 72.29% | 0.3(n.s) |
transport | GO:0006810 | 2 | 25% | 14.27% | 0.32(n.s) |
physiological process | GO:0007582 | 7 | 87.5% | 73.68% | 0.33(n.s) |
primary metabolism | GO:0044238 | 5 | 62.5% | 48.71% | 0.34(n.s) |
development | GO:0007275 | 1 | 12.5% | 5.73% | 0.38(n.s) |
cellular metabolism | GO:0044237 | 5 | 62.5% | 52.12% | 0.41(n.s) |
metabolism | GO:0008152 | 5 | 62.5% | 52.93% | 0.43(n.s) |
DNA metabolism | GO:0006259 | 1 | 12.5% | 8.58% | 0.51(n.s) |
biopolymer modification | GO:0043412 | 1 | 12.5% | 9.25% | 0.54(n.s) |
nucleobase, nucleoside, nucleotide and nucleic acid metabolism | GO:0006139 | 2 | 25% | 23.17% | 0.59(n.s) |
cellular physiological process | GO:0050875 | 6 | 75% | 71.65% | 0.59(n.s) |
biopolymer metabolism | GO:0043283 | 2 | 25% | 25.06% | 0.63(n.s) |
cellular biosynthesis | GO:0044249 | 1 | 12.5% | 17.05% | 0.78(n.s) |
cellular macromolecule metabolism | GO:0044260 | 1 | 12.5% | 24.52% | 0.89(n.s) |
macromolecule metabolism | GO:0043170 | 1 | 12.5% | 26.04% | 0.91(n.s) |
biological_process | GO:0008150 | 8 | 100% | 99.98% | 1(n.s) |
Name | ID | Count | Percent (Study Genes) | Percent (Population Genes) | E value |
lipid kinase activity | GO:0001727 | 2 | 25% | 0.12% | 3.75E-5(0.06) |
inositol or phosphatidylinositol kinase activity | GO:0004428 | 2 | 25% | 0.17% | 7.35E-5(0.12) |
1-phosphatidylinositol-3-phosphate 5-kinase activity | GO:0000285 | 1 | 12.5% | 0.02% | ** |
phosphatidylinositol phosphate kinase activity | GO:0016307 | 1 | 12.5% | 0.03% | 2.48E-3(n.s) |
1-phosphatidylinositol 4-kinase activity | GO:0004430 | 1 | 12.5% | 0.05% | 3.71E-3(n.s) |
oxysterol binding | GO:0008142 | 1 | 12.5% | 0.09% | 7.41E-3(n.s) |
steroid binding | GO:0005496 | 1 | 12.5% | 0.09% | 7.41E-3(n.s) |
protein kinase inhibitor activity | GO:0004860 | 1 | 12.5% | 0.09% | 7.41E-3(n.s) |
kinase inhibitor activity | GO:0019210 | 1 | 12.5% | 0.11% | 8.65E-3(n.s) |
protein binding | GO:0005515 | 3 | 37.5% | 7.39% | 0.02(n.s) |
phosphotransferase activity, alcohol group as acceptor | GO:0016773 | 2 | 25% | 2.62% | 0.02(n.s) |
transcription corepressor activity | GO:0003714 | 1 | 12.5% | 0.25% | 0.02(n.s) |
tubulin binding | GO:0015631 | 1 | 12.5% | 0.26% | 0.02(n.s) |
kinase activity | GO:0016301 | 2 | 25% | 3.05% | 0.02(n.s) |
enzyme inhibitor activity | GO:0004857 | 1 | 12.5% | 0.34% | 0.03(n.s) |
binding | GO:0005488 | 4 | 50% | 17.35% | 0.04(n.s) |
transferase activity | GO:0016740 | 3 | 37.5% | 10.13% | 0.04(n.s) |
transcription cofactor activity | GO:0003712 | 1 | 12.5% | 0.56% | 0.04(n.s) |
protein kinase regulator activity | GO:0019887 | 1 | 12.5% | 0.56% | 0.04(n.s) |
kinase regulator activity | GO:0019207 | 1 | 12.5% | 0.6% | 0.05(n.s) |
transcription factor binding | GO:0008134 | 1 | 12.5% | 0.6% | 0.05(n.s) |
cytoskeletal protein binding | GO:0008092 | 1 | 12.5% | 0.74% | 0.06(n.s) |
transferase activity, transferring phosphorus-containing groups | GO:0016772 | 2 | 25% | 5.19% | 0.06(n.s) |
enzyme regulator activity | GO:0030234 | 1 | 12.5% | 2.54% | 0.19(n.s) |
transcription regulator activity | GO:0030528 | 1 | 12.5% | 5% | 0.34(n.s) |
catalytic activity | GO:0003824 | 3 | 37.5% | 29.21% | 0.43(n.s) |
molecular_function | GO:0003674 | 8 | 100% | 99.44% | 0.96(n.s) |